Pharmacology · 2012 · 10 citations · 37 references
MedicinePharmacologyPharmacotherapyDementiaNeuropharmacologyPsychopharmacologyCholinergic NeurochemistryCholinergic PharmacologyCognitive ImpairmentNeurodegenerative Disease PharmacotherapyNeurodegenerative DiseasesNeuropsychiatric PharmacotherapyAcetylcholine MetabolismAnticholinergic DrugsCentral Cholinergic PharmacologyCholinergic Dysfunction In NeurodegenerationCholinergic Modulation Of CognitionCholinergic Modulation Of MemoryCognitive Enhancement By Cholinergic AgentsPharmacological Treatment Of Dementia
We report the case of a 74-year-old woman who presented with amnesia and positive serum anticholinergic activity (SAA), which disappeared after treatment with the cholinesterase inhibitor donepezil for 1 year. Her only other regular medications were topical glaucoma preparations. We suggest that mental stress, mild cognitive impairment and Alzheimer's disease pathology combined to generate SAA in this patient. We also consider that SAA may have subsequently become negative because of upregulation of acetylcholine production by donepezil, and because the patient's other medications and physical condition (including glaucoma) remained unchanged during the 1-year period.
37
Marshal F. Folstein, Susan E. Folstein, Paul R. McHugh · Journal of Psychiatric Research · 1975 · 86.9K citations
Clinical diagnosis of Alzheimer's disease
Guy M. McKhann, David A. Drachman, Marshall Folstein et al. · Neurology · 1984 · 28K citations · Full text
Alzheimer's Disease and Senile Dementia: Loss of Neurons in the Basal Forebrain
PJ Whitehouse, DL Price, R. G. Struble et al. · Science · 1982 · 3.6K citations